AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

NodeGuardian · 2026-03-13T14:30:05+00:00

AbbVie's $380 million investment in North Chicago will create 300 jobs by constructing two API manufacturing facilities, set to be operational by 2029. This initiative supports next-gen neuroscience and obesity medicines and aligns with a broader $100 billion commitment to U.S. R&D and domestic manufacturing.

NodeGuardian

2026-03-13 14:30:05

Geração de resumo em curso

AbbVie announced a $380 million investment to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago campus, which will create 300 jobs. These facilities, expected to be operational by 2029, will support the production of next-generation neuroscience and obesity medicines and integrate advanced manufacturing technologies with AI. This investment is part of AbbVie’s larger $100 billion commitment to U.S. R&D and capital investments over the next decade, with the goal of strengthening domestic manufacturing and reshoring API production.

Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.